Simbarashe Takuva

发表

Cost-effectiveness analysis of flucytosine as induction therapy in the treatment of cryptococcal meningitis in HIV-infected adults in South Africa

A. Parrish, J. Miot, H. Dawood, 2021, BMC Health Services Research.

Systematic Review And Meta-Analysis Knowledge, attitudes, and perceptions of long-acting reversible contraceptive methods among healthcare workers in sub-Saharan Africa

A. Musekiwa, T. Leong, Simbarashe Takuva, 2021 .

Cost-effectiveness analysis of flucytosine as induction therapy in the treatment of cryptococcal meningitis in HIV-infected adults in South Africa

A. Parrish, J. Miot, H. Dawood, 2020, BMC Health Services Research.

Effectiveness of the Ad26.COV2.S vaccine in health-care workers in South Africa (the Sisonke study): results from a single-arm, open-label, phase 3B, implementation study

A. Diacon, H. Mahomed, N. Garrett, 2022, The Lancet.

Safety of the single-dose Ad26.CoV2.S vaccine among healthcare workers in the phase 3b Sisonke study in South Africa

N. Garrett, I. Sanne, L. Fairall, 2021, medRxiv.

Association Between Anaemia And Low Birth Weight Among HIV -Infected Pregnant Women Aged 15 – 49 Years In Zimbabwe : A Cross-Sectional Study

N. Khamisa, Simbarashe Takuva, D. T. Chisare, 2020 .

Knowledge, attitudes, and perceptions of long-acting reversible contraceptive (LARC) methods among healthcare workers in sub-Saharan Africa: a systematic review and meta-analysis

A. Musekiwa, T. Leong, Simbarashe Takuva, 2020, medRxiv.

A Phase 2b Study to Evaluate the Safety and Efficacy of VRC01 Broadly Neutralizing Monoclonal Antibody in Reducing Acquisition of HIV-1 Infection in Women in Sub-Saharan Africa: Baseline Findings

J. Mascola, J. Ledgerwood, L. Corey, 2021, Journal of acquired immune deficiency syndromes.

Safety evaluation of the single-dose Ad26.COV2.S vaccine among healthcare workers in the Sisonke study in South Africa: A phase 3b implementation trial

N. Garrett, I. Sanne, L. Fairall, 2022, PLoS medicine.

Efficacy, safety, and immunogenicity of a booster regimen of Ad26.COV2.S vaccine against COVID-19 (ENSEMBLE2): results of a randomised, double-blind, placebo-controlled, phase 3 trial

A. Borobia, H. Schuitemaker, Andrew Gibson, 2022, The Lancet Infectious Diseases.

Vascular thrombosis after single dose Ad26.COV2.S vaccine in healthcare workers in South Africa: open label, single arm, phase 3B study (Sisonke study)

N. Garrett, L. Bekker, I. Sanne, 2023, BMJ medicine.

Infusion Reactions After Receiving the Broadly Neutralizing Antibody VRC01 or Placebo to Reduce HIV-1 Acquisition: Results From the Phase 2b Antibody-Mediated Prevention Randomized Trials

J. Mascola, J. Ledgerwood, L. Corey, 2021, Journal of acquired immune deficiency syndromes.

Sisonke phase 3B open-label study: Lessons learnt for national and global vaccination scale-up during epidemics.

L. Bekker, N. Garrett, I. Sanne, 2021, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.